At a glance
- Originator Kyowa Hakko
- Class Benzoxepins; Class IV antiarrhythmics; Small molecules
- Mechanism of Action Potassium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 14 Oct 1994 Discontinued-II for Arrhythmias in Japan (PO)